HomeZBIO • NASDAQ
add
Zenas Biopharma Inc
Previous close
$10.15
Day range
$10.05 - $10.20
Year range
$5.83 - $26.25
Market cap
426.71M USD
Avg Volume
177.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 10.00M | — |
Operating expense | 12.42M | 151.67% |
Net income | -33.57M | -20.77% |
Net profit margin | -335.73 | — |
Earnings per share | -0.80 | — |
EBITDA | -37.31M | -35.44% |
Effective tax rate | 0.61% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 312.38M | 740.77% |
Total assets | 333.77M | 580.45% |
Total liabilities | 49.45M | -3.91% |
Total equity | 284.32M | — |
Shares outstanding | 41.83M | — |
Price to book | 1.49 | — |
Return on assets | -26.52% | — |
Return on capital | -31.16% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -33.57M | -20.77% |
Cash from operations | -37.05M | -93.96% |
Cash from investing | -86.27M | -392,054.55% |
Cash from financing | 99.00K | 116.12% |
Net change in cash | -123.28M | -525.71% |
Free cash flow | -26.49M | -202.20% |
About
Founded
2019
Headquarters
Website
Employees
130
